Published in Am J Transplant on April 01, 2002
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transpl Int (2007) 2.03
A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation (2009) 1.79
Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol (2006) 1.53
Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1. Transpl Int (2012) 1.44
[Investigation of tubular reabsorption of phosphates in patients with chronic kidney disease]. Vnitr Lek (2015) 1.38
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. J Am Soc Nephrol (2005) 1.06
Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation. J Urol (2004) 1.06
Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett (2005) 1.02
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant (2005) 1.00
Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int (2008) 0.98
Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol (2003) 0.98
Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol (2009) 0.97
The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo vadis. Clin J Am Soc Nephrol (2011) 0.95
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy. Nephrol Dial Transplant (2009) 0.93
Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells. Transplantation (2006) 0.92
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation. Transpl Int (2012) 0.92
Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart. Stem Cells (2008) 0.92
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. Transpl Immunol (2002) 0.91
Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L. Transplantation (2007) 0.89
A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up. Transplantation (2012) 0.89
Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant (2011) 0.89
Combined costimulation blockade inhibits accelerated rejection mediated by alloantigen-primed memory T cells in mice. Immunol Invest (2009) 0.88
Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study. Nephrol Dial Transplant (2011) 0.87
Intrarenal cytokine and chemokine gene expression and kidney graft outcome. Kidney Blood Press Res (2007) 0.86
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transpl Int (2012) 0.86
Current status of transplantation and organ donation in the Balkans--could it be improved through the South-eastern Europe Health Network (SEEHN) initiative? Nephrol Dial Transplant (2012) 0.86
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol (2011) 0.85
Fundamental and distinct roles of P-selectin and LFA-1 in ischemia/reperfusion-induced leukocyte-endothelium interactions in the mouse colon. Ann Surg (2002) 0.85
Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range. Transplantation (2002) 0.85
Kidneys from marginal donors: views of patients on informed consent. Nephrol Dial Transplant (2002) 0.83
Calcineurin inhibitor sparing in renal transplantation. Transplantation (2008) 0.83
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study. Clin Transplant (2010) 0.82
CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice. Transplantation (2002) 0.81
Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wien Klin Wochenschr (2008) 0.81
Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clin Pharmacokinet (2009) 0.81
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Transpl Int (2005) 0.80
Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects. Nephrol Dial Transplant (2002) 0.80
Costimulation blockade in transplantation of nerve allografts: long-term effects. J Peripher Nerv Syst (2008) 0.79
Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid. Transplantation (2010) 0.79
Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice. Transpl Immunol (2011) 0.79
Blockade of CD27/CD70 pathway to reduce the generation of memory T cells and markedly prolong the survival of heart allografts in presensitized mice. Transpl Immunol (2011) 0.78
Isatis tinctoria L. combined with co-stimulatory molecules blockade prolongs survival of cardiac allografts in alloantigen-primed mice. Transpl Immunol (2010) 0.78
Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation (2002) 0.78
Immunomodulation by costimulation blockade inhibits rejection of nerve allografts. J Peripher Nerv Syst (2007) 0.78
Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L. Xenotransplantation (2002) 0.78
Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study. Kidney Blood Press Res (2008) 0.78
Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony Study. Transplantation (2009) 0.77
Asymmetric dimethylarginine in obesity after renal transplantation. J Ren Nutr (2008) 0.77
Combination of antibodies inhibits accelerated rejection mediated by memory T cells in xenoantigen-primed mice. Xenotransplantation (2010) 0.77
Downregulation of tissue factor (TF) by RNA interference induces apoptosis and impairs cell survival of primary endothelium and tumor cells. Cell Tissue Res (2008) 0.77
Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft. Transpl Immunol (2007) 0.77
Induction of operational tolerance to discordant dopaminergic porcine xenografts. Transplantation (2003) 0.77
Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant (2003) 0.77
Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor. Transplantation (2008) 0.77
An N-(alkylcarbonyl)anthranilic acid derivative prolongs cardiac allograft survival synergistically with cyclosporine A in a high-responder rat model. Transpl Immunol (2010) 0.76
Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol (2005) 0.76
Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr (2008) 0.76
Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study. Am J Kidney Dis (2003) 0.76
More on B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med (2009) 0.76
Interventional trials involving patients cannot be performed safely without a control group treated with the standard of care. Transplantation (2007) 0.75
[The most recent aspects of diagnosis and therapy of hyponatraemia]. Vnitr Lek (2015) 0.75
The relationship between estimated GFR based on the CKD-EPI formula and renal inulin clearance in potential kidney donors. Clin Nephrol (2014) 0.75
Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant (2006) 0.75
Importance of serum [Na+] and [Cl-] difference in acid-base status classification. Anesth Analg (2010) 0.75
[Disorders of water and electrolyte metabolism and changes in acid-base balance in patients with ascitic liver cirrhosis]. Cas Lek Cesk (2017) 0.75
[Metabolic acidosis in chronic kidney disease]. Vnitr Lek (2016) 0.75
[Granulomatosis with polyangiitis manifested as diabetes insipidus]. Vnitr Lek (2016) 0.75
Antibodies to HLA class II antigens as a risk factor for acute rejection of the allogeneic kindey. Ann Transplant (2004) 0.75
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study. Transpl Int (2009) 0.75
[Serum concentration and tubular resorption of sodium and chloride in patients with chronic renal disease]. Cas Lek Cesk (2015) 0.75
Effects of high-tone external muscle stimulation on renal function in healthy volunteers. Clin Nephrol (2013) 0.75
[Clinical evaluation of acid-base status: Henderson-Hasselbalch, or Stewart-Fencl approach?] Cas Lek Cesk (2016) 0.75
Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking. Transpl Int (2009) 0.75
Metabolic syndrome after renal transplantation. Med Pregl (2007) 0.75
[Present possibilities of monitoring the effectiveness of hyponatremia therapy]. Vnitr Lek (2016) 0.75
[The difference and ratio between serum concentrations of natrium and chlorides in patients with hyponatremia]. Vnitr Lek (2016) 0.75
Early-morning urine osmolality in patients with chronic allograft nephropathy. Transpl Int (2004) 0.75
Conversion to sirolimus of patients with chronic allograft nephropathy--a retrospective analysis of outcome and influencing factors. Langenbecks Arch Surg (2008) 0.75
Acid-base balance in peritoneal dialysis patients: a Stewart-Fencl analysis. Ren Fail (2009) 0.75
[Potential for organ donation in Sweden. Analysis of five-year registration of all ICU deaths in southern Sweden]. Lakartidningen (2005) 0.75
Medical-record review of potential donor pool in the Czech Republic suggests a possible increase to more than double the number of donors. Transpl Int (2003) 0.75